Hepatitis A Vaccine / 한양의대학술지
Hanyang Medical Reviews
;
: 16-23, 2008.
Artigo
em Coreano
| WPRIM
| ID: wpr-171146
ABSTRACT
Hepatitis A virus (HAV) is a RNA virus classified within Picornaviridae family HAV vaccines containing formalin-inactivated virus produced in cell culture have been licensed in the early 1990s. HAV seroepidemiology in Korea is rapidly changing according to improvement of socioeconomical status. This epidemiologic shift is presented by growing numbers of hepatitis A cases among young adults, who are more symptomatic than children. Recently, about 70% of acute viral hepatitis in Korean adults are attributable to HAV. The seroprevalence of HAV among the young people in their teens and twenties is only about 10%, which suggests that a growing number of young adults are susceptible to HAV infection and development of more cases with severe presentation is expected in the near future. Therefore, active campaign for childhood HAV vaccination should be continued, and catch-up vaccination for the young population should be considered in Korea. Some preliminary data suggest the incidence rate of hepatitis A might be higher than 20/100,000 population, and routine childhood vaccination for HAV could be cost-effective in Korea. To provide reasonable recommendation for HAV vaccine, the continuous survey of HAV seroepidemiology and study on the cost-effectiveness of routine childhood vaccination are urgently warranted.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Picornaviridae
/
Vírus de RNA
/
Vírus
/
Vacinas
/
Estudos Soroepidemiológicos
/
Incidência
/
Vacinação
/
Técnicas de Cultura de Células
/
Vacinas contra Hepatite A
/
Vírus da Hepatite A
Tipo de estudo:
Estudo de incidência
/
Estudo prognóstico
Limite:
Adolescente
/
Adulto
/
Criança
/
Humanos
País/Região como assunto:
Ásia
Idioma:
Coreano
Revista:
Hanyang Medical Reviews
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS